BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mbefo M, Berger A, Schouwey K, Gérard X, Kostic C, Beryozkin A, Sharon D, Dolfuss H, Munier F, Tran HV, van Lohuizen M, Beltran WA, Arsenijevic Y. Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy. Int J Mol Sci 2021;22:9331. [PMID: 34502238 DOI: 10.3390/ijms22179331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Moore SM, Christoforidis JB. Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review. Genes (Basel) 2023;14. [PMID: 36833344 DOI: 10.3390/genes14020417] [Reference Citation Analysis]
2 Zhao L, Hou C, Yan N. Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system. Front Immunol 2022;13:1059947. [PMID: 36389729 DOI: 10.3389/fimmu.2022.1059947] [Cited by in F6Publishing: 1] [Reference Citation Analysis]